When the majority of new drug candidates are developed for oral or some other extravascular dose route, it is easy to understand why pharmaceutical companies may seek to avoid or delay the generation ...
Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious adverse events observed for GTX-104 LAVAL, Québec, May 18, 2022 (GLOBE NEWSWIRE) — Acasti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback